Selecting adequate antibacterial therapy for the treatment of COPD exacerbations

Abstract

COPD exacerbations have a negative impact on patient's quality of life, lead to worsening of clinical symptoms and function of the lung. COPD, being a major cause of seeking medical aid, is associated with a significant mortality and results in considerable economic and social costs. Taking into account current recommendations for the treatment of COPD and research data on the resistance of respiratory pathogens, inhibitor-protected penicillin for oral administration may be considered a medicine of choice in the empirical antibiotic therapy for mild to moderate COPD exacerbations.

Keywords

• хроническая обструктивная болезнь легких
• антибактериальная терапия
• защищенные пенициллины
• chronic obstructive pulmonary disease
• antibiotic therapy
• inhibitor-protected penicillins